Clarithromycin extended-release - Abbott Laboratories
At a glance
- Drug Originator Abbott Laboratories
- Drug Class Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 3
- NDAs 1
- Patent Applications 4,482
Table of Contents
Disclaimer